MAPT and neurodegenerative disease: When determining how EGCG may be used pharmacologically, it is important to discuss a few key findings regarding its mechanism when interacting with proteins like tau and α-syn, which are involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease.